Former Evotec COO joins Orbit Discovery’s Board of Directors
Mario Polywka, the recently retired COO of pharma company Evotec, joined Orbit Discovery’s Board of Directors at the beginning of September 2019.
Mario brings exceptional operational, commercial and strategic development experience to Orbit Discovery. He was COO of 12 years at Evotec and remains on its Supervisory Board, as well as being a board member of Forge Therapeutics and Exscientia. Mario has previously held CEO, Chair and Non-executive Director positions at Oxford Asymmetry International, as well as a number of Oxford and Southampton University spinout companies.
Click here for the official Company press release.